🇺🇸 FDA
Patent

US 9351962

Modulators of cystic fibrosis transmembrane conductance regulator

granted A61KA61K31/427A61P

Quick answer

US patent 9351962 (Modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/427, A61P, A61P1/00, A61P1/12